The rabbit polyclonal RS antibody was raised against a synthetic peptide corresponding to the amino acid residues 24-37 of RS.
13 The following antibodies were also used: human factor VIII; lactase dehydrogenase (LDH); the α subunit of Na
+,K
+-ATPase; rhodopsin; collagen types I, IV and XVII (Santa Cruz Biotechnology, Santa Cruz, CA); monoclonal anti-collagen type II and III (Sigma-Aldrich, St. Louis, MO); anti-Cyt Oxi IV (MitoSciences, Eugene, OR); non-NMDA receptor subunit I (gift from Robert Wenthold, NIDCD/NIH); flottilin 1 (BD Biosciences, Franklin Lakes, NJ), and anti-glutathione S-transferase (GST) (GE Healthcare/Life Sciences, Piscataway, NJ). Reagents were collagens, human lung type I, bovine type II and III (Southern Biotech, Birmingham, AL); mouse collagen IV (Cultrex; Trevigen, Gaithersburg, MD); Igepal CA630/NP40, glutathione, isopropyl-β-
d-thiogalactoside, imidazole, phospholipase C from
Bacillus cereus (Sigma-Aldrich); PIP Strips (Echelon Biosciences, Salt Lake City, UT); glutathione-Sepharose, chemiluminescent Western blot detection reagent, and secondary horseradish peroxidase–linked anti-mouse or anti-rabbit IgG (GE Healthcare/Life Sciences); phospholipids (Avanti Polar Lipids Inc., Alabaster, AL); Factor VIII (Bayer Health Care, Leverkusen, Germany); and protease inhibitor cocktail tablets (Roche Diagnostics, Indianapolis, IN). Analytical grade reagents were obtained from Sigma-Aldrich, Bio-Rad Laboratories (Hercules, CA), or Electron Microscopy Sciences (Hatfield, PA).